Scientists Develop HANABI Device to Identify Toxic Aggregates in Parkinson’s Patients’ Brains

Scientists Develop HANABI Device to Identify Toxic Aggregates in Parkinson’s Patients’ Brains
A new test can analyze cerebrospinal fluid samples and help measure how many toxic aggregates of alpha-synuclein can be found in the brains of patients with Parkinson’s disease. The new assessment strategy was developed by Japanese researchers and was reported in a study, “Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid,” published in Nature Scientific Reports. Parkinson’s disease is ... read more
Source: Parkinson’s News TodayPublished on 2019-05-13By Joana Carvalho